Biotech Restructurings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Restructurings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (25)	10/9/2002 7:27:31 PM
From: Icebrg	Read Replies (2) of 270

>>I don't follow NWBT, no application of comments to the company>> Some comments on NWBT. I believe their PSMA-directed antibody should be of interest. Millennium and Cytogen/Progenics are running very similar programs. IP situation is somewhat unclear. All three of them are preparing immunoconjugates with their respective antibodies as carriers. I suppose this mAb and project will end up with Medarex. Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next